Jonathan Craig Blain

This inventor holds 1 USPTO granted patent. Top assignee: Arrakis Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Craig Blain. Retrieved from https://idiyas.com/inventor/jonathan-craig-blain-fz44pobh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jonathan Craig Blain

Introduction

Jonathan Craig Blain is an accomplished inventor known for his contributions to the field of biotechnology. He is currently associated with Arrakis Therapeutics, Inc., where he focuses on developing innovative solutions in nucleic acid technology. His work has significant implications for therapeutic applications.

Latest Patents

Jonathan holds a patent titled "Nucleic Acid-Binding Photoprobes and Uses Thereof." This patent showcases his expertise in creating photoprobes that can bind to nucleic acids, which can be pivotal in various research and medical applications. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Throughout his career, Jonathan has demonstrated a commitment to advancing scientific knowledge and technology. His role at Arrakis Therapeutics, Inc. has allowed him to collaborate with other talented professionals in the industry, further enhancing his impact on biotechnology.

Collaborations

Jonathan has worked alongside notable colleagues, including Donovan Noel Chin and Herschel Mukherjee. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Jonathan Craig Blain's work exemplifies the spirit of innovation in biotechnology. His contributions, particularly in nucleic acid technology, continue to pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…